The Company expects to submit the New Drug Application for Xulane Lo in the second half of 2025. A low dose combination hormonal patch was found to be effective for pregnancy prevention based on ...

Pharmaceutical giant Johnson & Johnson may have known years ago about the deadly risks of its birth control patch Ortho Evra, according to internal documents obtained by NBC News. Patient reports ...

- UNDATED HANDOUT PHOTO - Johnson & Johnson won U.S. approval to sell Ortho Evra, the first contraceptive skin patch, the Food and Drug Administration said November 20, 2001. The patch releases ...

Birth control effectiveness varies by method, with implants, IUDs, and sterilization preventing pregnancy over 99% of the time. Pills, patches, and condoms are also reliable but depend more on correct ...